- Case Report
- Open Access
Atrial thrombus as a complication of SLE and APS in an 8-year-old child
Pediatric Rheumatology volume 18, Article number: 90 (2020)
Systemic lupus erythematosus (SLE) is an autoimmune disease involving multiple systems with various clinical manifestations. Renal involvement is common, but intracardiac thrombus is rarely reported as a complication of antiphospholipid syndrome (APS, also known as anticardiolipin syndrome). Anticoagulant therapy is the first-line treatment, and surgery is performed in severe cases. We report a case to improve clinicians’ understanding of disease diagnosis.
An 8-year-old girl was admitted to our hospital because of left costal pain, hematuria and fever. She had obvious edema occult blood 3+, urinary protein 3.2 g/24 h, albumin 17.6 g/L, and total cholesterol 7.21 mmol/L, consistent with a diagnosis of nephrotic syndrome. We continued to track the etiology of nephrotic syndrome and performed a renal biopsy, showing dsDNA 1:10 positivity, low C3, low platelets and hemoglobin, anticardiolipin IgM 12 U/ml, anti-β2-glycoprotein I (β2GPI) 223 U/ml; renal pathology suggested lupus nephritis (LN), and the patient was ultimately diagnosed with SLE, secondary APS and LN. The patient was treated with hormones and immunosuppressants. Sixteen weeks later, her urinary protein was 1+, and the quantity of urine protein was less than 0.5 g/d. Echocardiography showed that the mass in the right atrium was thrombotic. Heparin anticoagulant therapy was effective.
SLE can involve multiple systems and various complications. Thrombus in the right atrium is a rare complication of APS. Early diagnosis and treatment are key to improving the prognosis of children.
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease with various clinical manifestations. Lupus nephritis (LN) is a common manifestation of SLE. Anticardiolipin antibody syndrome is easily complicated by thrombi, but intracardiac thrombosis is rare. Here, we report a child with nephrotic syndrome who was then diagnosed with SLE and secondary anticardiolipin antibody syndrome complicated by right atrial thrombus.
An 8-year-old female who presented with left rib pain, hematuria and fever was admitted to our hospital. The maximum temperature reached 39.9 °C, with no chills or rash. She was administered cefepime and azithromycin for 1 day, cefotaxime for 5 days, and methylprednisolone for 1 day. On physical examination, her general condition was poor, with eyelid and lower limb edema; coarse respiratory sounds and auscultation of blisters of both lungs were noted, and no other abnormal findings were present at that time. Laboratory findings were as follows: white blood cell count 6.32*109/L, neutrophil 0.48, lymphocyte 0.42, red blood cell count 3.40*1012/L, hemoglobin 93 g/L, and platelet count 48*1012/L. Her urine revealed 363.69 red blood cells/high-powered field (hpf), protein 3+, 5.1 white blood cells/hpf, erythrocyte sedimentation rate (ESR) 135 mm/h, C-reactive protein (CRP) 25.2 mg/L, albumin 17.6 g/L, total cholesterol 7.21 mmol/L, and urinary protein 3.2 g/24 h. Other laboratory findings included activated partial thromboplastin time (APTT) 138.7 s, direct antiglobulin test positive, ferritin 358.4 μg/L, D-dimer 4937.00 μg/L, and FDG 33.8 μg/ml. Serum showed C3 0.92 g/L (0.9–1.8), C4 0.17 g/L (0.1–0.4), ANA:anti-SSA-60 ±, anti-nRNP/Sm positivity, homogeneous 1:3200 positivity, dsDNA 1:10 positivity, antinucleoome antibody positivity, antimitochondrial M2 positivity, anticardiolipin IgM 12 U/ml (0–10), and anti-β2GPI 223 U/ml (0–20). Bone marrow biopsy revealed secondary anemia, and globular red blood cells accounted for 5.5%. However, respiratory pathogens, myocardial enzymes, mycoplasma pneumoniae/chlamydia antibodies, procalcitonin, folic aci, vitamin B12, reticulocytes, bacterial cultures of blood, stool, tuberculosis spots, Epstein-Barr virus, cytomegalovirus, ANCA were all negative. Hematuria location: urine abnormal red blood cell 60%, urine uniform red blood cell 40%. Bronchoscope results showed inflammation of the endobronchial membrane. Pulmonary CT revealed patchy high-density shadows in all lobes of the lungs, especially in the lower lobes of the lungs (Fig. 1). Color Doppler ultrasonography of the lower limbs ruled out deep vein thrombosis. Abdominal color ultrasound revealed abdominal effusion. Echocardiography showed a kind of round moderate echo with a diameter of approximately 2.0 cm that could be seen at the bottom of the right atrium near the opening of the inferior vena cava. The patient was diagnosed with right atrial thrombus (Fig. 2). Renal pathology using light microscopy revealed 52 glomeruli in the renal tissue; there were 52 glomeruli in the renal tissue, with slight proliferation of mesangial cells and mesangial matrix, swelling and slight proliferation of segmental foot nuclear endothelial cells, slight thickening of glomerular basement membrane and a large amount of phenophilin deposition in subepithelial cells. No microthrombi or crescents were observed, and a small amount of inflammatory cell infiltration dominated by neutrophils was found in some glomeruli. There was slight edema in the renal interstitium, and there was no renal tubular atrophy and obvious inflammatory cell infiltration and fibrosis. No obvious abnormalities were found in the arterioles. Immunofluorescence analysis was positive for IgA, IgM, IgG, C3, C4, and C1q deposited along the glomerular capillary wall and segmental mesangial area. The above features were consistent with membranous LN with mesangial proliferative LN (consistent with types V and II LN) (Figs. 3 and 4). Nephrotic syndrome is a common disease in children that is characterized by edema, massive proteinuria (>50 mg/kg.24 h), hypoproteinemia (<25 g/l) and hypercholesterolemia (>5.7 mmol/l). Our patient’s disease characteristics were consistent with those of nephrotic syndrome . We continued to track the etiology of nephrotic syndrome, and the child had no family history of renal disease; therefore, we investigated secondary factors, including serology results that were positive for ANA and anti-dsDNA with low C3 levels. Although her platelets and hemoglobin levels were significantly lower than normal, she had no rash, arthralgia, photosensitivity, oral ulcer, or butterfly erythema, so a renal biopsy was performed, which suggested LN. The patient was finally diagnosed with SLE and LN. She was treated with pulse methylprednisolone for 3 days and IV diuretic with albumin, followed by oral steroids 1 mg/kg.d after 3 days, with rapid resolution of edema. Anticardiolipin IgM of 12 U/ml and anti-β2GPI of 223 U/ml were consistent with secondary APS. What was the cause of the space-occupying mass in the right atrium? At this point, as no clear etiological evidence was found, a repeated echocardiography indicated that the nature of the right atrial mass was a thrombus. The mass was reduced by anticoagulant therapy with heparin for 2 weeks. By 3 weeks, proteinuria decreased to 1.0 g/day, and by 16 weeks, she was in complete remission with < 0.5 g proteinuria. After 6 months of follow-up, the patient has remained in complete remission, but 2.5 mg of prednisolone is administered each day.
Systemic lupus erythematosus (SLE) is an autoimmune disease that can involve multiple organs. Its pathological manifestations are immune complex deposition and vasculitis changes. Lupus nephritis (LN) is a common manifestation of SLE. In the early stage of SLE, LN may show slight abnormalities in urine (microhematuria, albuminuria) [2,3,4,5], with nephrotic syndrome, hypertension, or renal failure [6, 7]. In this case, the child was diagnosed with nephrotic syndrome, and renal biopsy revealed LN. According to the International Society of Nephrology (ISN/RPS), LN is divided into six grades (grades I-VI) . Nephrotic syndrome is usually associated with diffuse or membranous. LN . However, membranous LN or mesangial proliferative LN is rare in children. Echocardiography revealed an occupying mass in the right atrium. The nature of the mass is usually a neoplasm, tumor, or thrombus. The neoplasms are most common on the valves, and no neoplasms were found by echocardiography. Scholars  have pointed out that myxoma is the most common cardiac tumor, is usually located in the left atrium, and is usually attached to the atrial septum. Cardiac myxoma is mostly found in the left atrium, which is mostly attached to the atrial septum, accounting for approximately 15% of the right atrium, while atrial thrombus is more common in the left atrial appendage. Thrombi in the right atrium are rare. How can an atrial thrombus and a cardiac myxoma be distinguished? In fact, the identification of the two is mainly determined using ultrasound, and generally speaking, the identification is not very difficult. Cardiac myxoma can be accompanied by blood flow fluctuations, but a thrombus generally is not. The shape of cardiac myxoma can change with the relaxation or contraction of the heart, but a thrombus will not. Anticoagulants can dissolve part of the thrombus, but cardiac myxoma cannot be dissolved by anticoagulants. The volume of the atrial mass was reduced in our patient after anticoagulation with heparin.
Our pediatric patient was diagnosed with APS with a right atrial thrombus; intracardiac thrombosis is a rare complication of antiphospholipid syndrome (APS), and the physiological mechanism is not clear. The hypercoagulable state of nephrotic syndrome can easily lead to thrombosis, and SLE with positive anticoagulant activity or medium or high levels of anticardiolipin antibody can increase the risk of thrombosis or thromboembolism in the heart . Thirty-seven percent of SLE patients with anticardiolipin antibody syndrome were positive for the β2GPI antibody , which is an independent risk factor for thrombosis . The chronic inflammatory state of SLE also increases the risk of thrombosis. Some scholars  have pointed out that thrombosis is related to the presence of lupus anticogulant (LAC)-positive and anti-RNP/Sm antibodies, and the combined use of LAC and anti-RNP/Sm antibodies as predictors of venous thromboembolism is worth studying. In this case, our patient had a right atrial thrombosis that was associated with secondary APS, which has a higher risk of thrombosis and valvular disease than patients who do not have antiphospholipid antibodies . In addition, others [10, 16, 17] have pointed out that when the thrombus in the cardiac cavity is large and irregular, it easly falls off and leads to a very high risk of recurrent pulmonary embolism. In this patients, pulmonary CT showed inflammation and consolidation changes in both lungs (Fig. 1). The patient was treated with the anticoagulant heparin, and echocardiography showed that the volume of the thrombus was reduced, so no surgery was performed to remove the thrombus. Therefore, for SLE patients with high risk factors for thrombosis, attention should be paid to screen for thrombi and to treat with anticoagulation therapy in a timely manner.
In summary, we report a rare case of atrial thrombosis caused by secondary APS. Atrial thrombi are rare, and anticoagulant therapy is the first-line treatment. This case report is presented to improve clinicians’ understanding of the disease, to find the real cause behind the disease, early diagnosis and treatment, and to improve the prognosis of patients. For adolescents, when multiple systems are involved, the diagnosis is most likely to be SLE. The diagnosis of SLE can be confirmed by conducting an immunological examination and a renal biopsy as soon as possible.
Availability of data and materials
Systemic lupus erythematosus
C reactive protein
Erythrocyte sedimentation rate
Activated partial thromboplastin time
Tiwari S, Seth A. Nephrotic syndrome in children-a tale of 50 years. Indian Pediatr. 2016;53(12):1097–8.
Wu XY, Yang M, Xie YS, et al. Causes of death in hospitalized patients with systemic lupus erythematosus: a 10-year multicenter nationwide Chinese cohort. Clin Rheumatol. 2019;38(1):107–15.
Smith EMD, Lythgoe H, Midgley A, et al. Juvenile-onset systemic lupus erythematosus: update on clinical presentation, pathophysiology and treatment options. Clin Immunol. 2019;209:108274.
Jin SY, Huang DL, Dang XQ, et al. Lupus glomerulonephritis in 788 Chinese children: a multi-centre clinical and histopathological analysis based on 549 renal biopsies. Paediatr Int Child Health. 2017;37(4):286–91.
Fanouriakis A, Kostopoulou M, Alunno A, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736–45.
Schwartz N, Goilav B. The pathogenesis, diagnosis and treatment of lupus nephritis. Curr Opin Rheumatol. 2014;26:502–9.
Hahn BH, McMahon MA, Wilkinson A, et al. American College Rheumatology guidelines for screening, case definition, treatment, and management of lupus nephritis. Arthritis Care Res. 2012;64:797–808.
Nagata M. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004;65:521–30.
Ito I, Nishida M, Morioka S, et al. A case of steroid-resistant nephrotic syndrome associated with systemic lupus erythematosus. Lupus. 2014;23(7):703–6.
Cianciulli TF, Saccheri MC, Redruello HJ, et al. Right atrial thrombus mimicking myxoma with pulmonary embolism in a patient with systemic lupus erythematosus and secondary antiphospholipid syndrome. Tex Heart Inst J. 2008;35:454–7.
Ma J, Song H, Wei M, et al. Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients. Clin Rheumatol. 2018;37(5):1295–303.
Bruce IN, Clark-Soloninka CA, Spitzer KA, et al. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review. J Rheumatol. 2000;27(27):2833–7.
Reber G, Moerloose PD. Anti-beta2-glycoprotein I antibodies--when and how should they be measured? Thromb Res. 2004;114(5–6):527–31.
Hinojosa-Azaola A, Romero-Diaz J, Vargas-Ruiz AG, et al. Venous and arterial thrombotic events in systemic lupus erythematosus. J Rheumatol. 2016;43(3):576–86.
Kaplan SD, Chartash EK, Pizzarello RA, et al. Cardiac manifestations of the antiphospholipid syndrome: an unusual cause of fever of unknown origin with review of literature. J Cardiol Cases. 2016;14:1331–8.
Dhibar DP, Sahu KK, Varma SC, et al. Intra-cardiac thrombus in antiphospholipid antibody syndrome: an unusual cause of fever of unknown origin with review of literature. J Cardiol Cases. 2016;14:153–6.
Khalid U, Hirudayaraj P, Lakkis N, et al. Left atrial thrombus mimicking a myxoma in a patient with systemic lupus erythematosus. Hell J Cardiol. 2014;55:167–70.
Consent for publication
Consent has been given by the parents.
None of the authors have any financial or any non-financial competing interests to declare in relation to this manuscript.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Yan, Hb., Li, Ym. Atrial thrombus as a complication of SLE and APS in an 8-year-old child. Pediatr Rheumatol 18, 90 (2020). https://doi.org/10.1186/s12969-020-00484-z
- Systemic lupus erythematosus
- Nephrotic syndrome
- Anticardiolipin antibody syndrome
- Atrial thrombus